160194-39-8 Usage
Description
2-5-[(1H-1,2,4-TR IAZOOL-1-YL)METHYL]INDOOL-3-YLETHAAN-1-OL, also known as 5-(1H-1,2,4-Triazol-1-ylmethyl)-1H-indole-3-ethanol, is an organic compound that serves as a crucial intermediate in the pharmaceutical industry. It is characterized by its unique molecular structure, which includes a triazole and indole ring, making it a valuable component in the development of various drugs.
Uses
Used in Pharmaceutical Industry:
2-5-[(1H-1,2,4-TR IAZOOL-1-YL)METHYL]INDOOL-3-YLETHAAN-1-OL is used as an intermediate in the synthesis of Rizatriptan Benzoate (R545000), a selective serotonin 5-HT1D receptor agonist. 2-5-[(1H-1,2,4-TR IAZOOL-1-YL)METHYL]INDOOL-3-YLETHAAN-1-OL is recognized for its potential as an anti-migraine drug, offering a targeted approach to alleviate the symptoms of migraines by specifically activating the 5-HT1D receptors.
The compound's role in the synthesis of Rizatriptan Benzoate highlights its importance in the development of effective treatments for migraine sufferers. By acting as a key intermediate, 2-5-[(1H-1,2,4-TR IAZOOL-1-YL)METHYL]INDOOL-3-YLETHAAN-1-OL contributes to the creation of a drug that can provide relief from the debilitating pain associated with migraines, improving the quality of life for many individuals.
Check Digit Verification of cas no
The CAS Registry Mumber 160194-39-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,0,1,9 and 4 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 160194-39:
(8*1)+(7*6)+(6*0)+(5*1)+(4*9)+(3*4)+(2*3)+(1*9)=118
118 % 10 = 8
So 160194-39-8 is a valid CAS Registry Number.
160194-39-8Relevant articles and documents
COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DISEASES
-
Page/Page column 28, (2008/06/13)
This invention relates to CXCR4 inhibitors and their use in treating and/or preventing a variety of angiogenic, microvascular and ocular disorders including primary indications for diabetic retinopathy, macular degeneration (such as wet or neovascular age
Azetidine, pyrrolidine and piperidine derivatives
-
, (2008/06/13)
A class of substituted azetidine, pyrrolidine and piperidine derivatives are selective agonists of 5-HT1 -like receptors, being potent agonists of the human 5-HT1Dα receptor subtype whilst possessing at least a 10-fold selective affinity for the 5-HT1Dα receptor subtype relative to the 5-HT1Dβ subtype; they are therefore useful in the treatment and/or prevention of clinical conditions, in particular migraine and associated disorders, for which a subtype-selective agonist of 5-HT1D receptors is indicated, whilst eliciting fewer side-effects, notably adverse cardiovascular events, than those associated with non-subtype-selective 5-HT1D receptor agonists.